Erschienen in:
01.06.2014 | Original Paper
HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda
verfasst von:
Ned Sacktor, Noeline Nakasujja, Andrew D. Redd, Jordyn Manucci, Oliver Laeyendecker, Sarah K. Wendel, Stephen F Porcella, Craig Martens, Daniel Bruno, Richard L. Skolasky, Ozioma C. Okonkwo, Kevin Robertson, Seggane Musisi, Elly Katabira, Thomas C. Quinn
Erschienen in:
Metabolic Brain Disease
|
Ausgabe 2/2014
Einloggen, um Zugang zu erhalten
Abstract
HIV-associated neurocognitive disorders (HAND) are a common neurological manifestation of HIV infection. A previous study suggested that HIV dementia may be more common among patients with subtype D virus than among those with subtype A virus among HIV+ individuals with advanced immunosuppression. We conducted a study to evaluate the frequency of HIV dementia, and the association of HIV dementia with HIV subtype and compartmentalization among HIV+ individuals with moderate and advanced immunosuppression (CD4 lymphocyte count >150 cells/μL and <250 cells/μL). The study enrolled 117 antiretroviral naïve HIV+ individuals in Kampala, Uganda. HIV+ individuals received neurological, neuropsychological testing, and functional assessments, and gag and gp41 regions were subtyped. Subjects were considered infected with a specific subtype if both regions analyzed were from the same subtype. 41 % of the HIV+ individuals had HIV dementia (mean CD4 lymphocyte count = 233 cells/μL). 67 individuals had subtype A, 25 individuals had subtype D, 24 individuals were classified as A/D recombinants, and one individual had subtype C. There was no difference in the frequency of HIV dementia when stratified by HIV subtype A and D and no association with compartmentalization between the cerebrospinal fluid and peripheral blood. These results suggest that HIV dementia is common in HIV+ individuals in Uganda. There was no association between HIV subtype and dementia among HIV+ individuals with moderate and advanced immunosuppression. Future studies should be performed to confirm these results.